Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 30Neoplasms 11Thyroid Neoplasms 7Thyroid Carcinoma, Anaplastic 6Brain Neoplasms 6Multiple Myeloma 4Glioma 4Colorectal Neoplasms 4Hematologic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thyroid Cancer, Papillary 2Skin Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Glioblastoma 2Astrocytoma 2Ameloblastoma 2Adenocarcinoma, Follicular 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid cancer, follicular 1Thyroid cancer, Hurthle cell 1Stomach Neoplasms 1Spinocerebellar Degenerations 1Solid Tumor 1Rectal Neoplasms 1Rare Malignant Neoplasm 1Prostatic Neoplasms 1Pancreatic Neoplasms 1

Interventions

vandetanib 1trametinib 1pralsetinib 1lenvatinib 1larotrectinib 1entrectinib 1donafenib 1dabrafenib 1cabozantinib 1apatinib 1anlotinib 1Sorafenib 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Locally Advanced Thyroid Gland Carcinoma × dabrafenib × Clear all
NCT06482086 2024-12-05

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

West China Hospital

Phase 2 Recruiting
75 enrolled
Head & Neck

Locally Advanced Thyroid Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡